Evaluation of neoadjuvant chemotherapy effects on liver parenchyma in resected pediatric malignancies

Pediatric Hematology and Oncology

Volumn 30, Issue 5, 2013, Pages 392-399

  Grazia Scuderi, Maria ^a   Magro, Gaetano ^a   Di Cataldo, Andrea ^a   Pesce, Antonino ^a   Scalora, Luisa ^a   Vecchio, Giada Maria ^a   Portale, Rosanna ^a   Benedetto, Vincenzo Di ^a   Puleo, Stefano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chemotherapy; Hepatology; Liver tumors; Pathology

Indexed keywords

ANTINEOPLASTIC AGENT; BILIRUBIN; CARBOPLATIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; OXALIPLATIN; SORAFENIB; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FATTY LIVER; FEMALE; HEPATOBLASTOMA; HUMAN; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; LIVER PARENCHYMA; LIVER RESECTION; MALE; PATIENT SATISFACTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SARCOMA; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG-INDUCED LIVER INJURY; FEMALE; FOLLOW-UP STUDIES; HEPATOCYTES; HUMANS; INFANT; LIVER; LIVER NEOPLASMS; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84880393427     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.788592     Document Type: Article

References (18)

1. Lautz TB, Ben-Ami T, TantemsapyaN, et al. Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma. Cancer. 2011;117:1976-1983
2. Kavlakoglu B, Ustun I, Oksuz O, et al. Surgical treatment of liver metastases from colorectal cancer: Experience of a single institution. Arch Iran Med. 2011;14:120-125
3. Isoniemi H, ? Osterlund P. Surgery combined with oncological treatments in liver metastases from colorectal cancer. Scand J Surg. 2001;100:35-41
4. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677-3683
5. Takamoto T,Hashimoto T, Sano K, et al. Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis. Ann Surg Oncol. 2010;17:2747-2755
6. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460-466
7. Parikh AA, Gentner B, Wu TT, et al. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg. 2003;7:1082-1088
8. NaritaM,Oussoultzoglou E, Chenard MP, et al. Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal embolisation. Surg Today. 2011;41:7-17
9. Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-Associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274-286
10. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1-7
11. Morris-Stiff, Tan Y-M, Vauthey JN.Hepatic complications following preoperative chemotherapywith oxaliplatin or irinotecan for hepatic colorectalmetastases. Eur J Surg Oncol. 2008;34:609-614
12. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer. 2000;36:1418-1425
13. Tumino M, Licciardello M, Sorge G, et al. Kabuki syndrome and cancer in two patients. Am J Med Genet A. 2010;152A:1536-1539
14. DiCataldoA,DiBenedetto F, BertunaG, et al. Transarterial chemoembolisation forhepatoblastoma: A case report. Ital J Pediatr. 2007;33:302-304
15. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85:3005-3020
16. Farruggia P, Macaluso A, Tropia S, et al. Hepatopathy-Thrombocytopenia syndrome after actinomycin-D therapy: Report of three cases and review of the literature. Pediatr Hematol Oncol. 2011;28:237-243
17. Perilongo G, Maibach R, Shafford E, et al. Cisplatin versus cisplatin plus doxorubicin for standardrisk hepatoblastoma.N Engl J Med. 2009;361:1662-1670
18. Welsh FK, Tilney HS, Tekkis PP, et al. Safe liver resection following chemotherapy for colorectal metastases is amatter of timing. Br J Cancer. 2007;96:1037-1042